Microtubule-damaging drugs triggered Bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of Bcl2 protein

International Journal of Oncology

Volumn 13, Issue 4, 1998, Pages 659-664

  Basu, Aruna ^a   Haldar, Subrata ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Apoptosis; Bcl2; Damaging agents; Microtubule; Phosphorylation; Site directed mutagenesis

Indexed keywords

DOLASTATIN; PROTEIN BCL 2; SERINE; VINBLASTINE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; MICROTUBULE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BENZOQUINONES; BINDING SITES; COLCHICINE; DEMECOLCINE; ENZYME INHIBITORS; GOUT SUPPRESSANTS; HUMANS; LACTAMS, MACROCYCLIC; MICROTUBULES; MUTAGENESIS, SITE-DIRECTED; PACLITAXEL; PHOSPHORYLATION; PODOPHYLLOTOXIN; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-RAF; QUINONES; SERINE; TUMOR CELLS, CULTURED;

EID: 0031671581     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.4.659     Document Type: Article

References (37)

1. Tsujimoto Y, Finger L, Yunis J, Nowell PC and Croce CM: Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226: 1097-1099, 1984.
2. Tsujimoto Y, Cossman J, Jaffe E and Croce CM: Involvement of the Bcl2 gene in follicular lymphoma. Science 228: 1440-1443, 1985.
3. Bakshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epsein AL and Korsmeyer SJ: Cloning the chromosomal breakpoint of the t(14;18) human lymphomas, clustering around JH on chromosome 14 and near a transcriptional unit 18. Cell 41: 889-906, 1985.
4. Cleary ML, Smith SD and Sklar J: Cloning and structural analysis of cDNAs for bcl2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14,18) translocation. Cell 47: 19-28, 1986.
5. Vaux DL, Cory S and Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442, 1988.
6. Hockenbery D, Nunez G, Milliman C, Schreiber RD and Korsmeyer SJ: Bcl2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336, 1990.
7. Reed JC: Double identity for proteins of the Bcl2 family. Nature 387: 773-776, 1997.
8. Kroemer G: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3: 614-620, 1997.
9. Basu A and Haldar S: Apoptosis, antiapoptosis and Bcl2. EOS-J Immunol Immunopharmacol 16: 41-47, 1996.
10. White E: Life, death and the pursuit of apoptosis. Genes Dev 10: 1-15, 1996.
11. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
12. Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 75: 609-619, 1993.
13. Yang E and Korsmeyer SJ: Molecular thanaptosis, a discourse on the BCL2 family and cell death. Blood 88: 386-401, 1996.
14. Kitada S, Krajewski S, Miyashita T, Krajewska M and Reed JC: Gamma-radiation induces upregulation of Bax protein and apoptosis in radiosensitive cells in vivo. Oncogene 12: 187-192, 1996.
15. Selvakumaran M, Lin H-K, Miyashita T, Wang GW, Krajewski S, Reed JC, Hoffman B and Liebermann D: Immediate early upregulation of bax expression by p53 but not TGF B1, a paradigm for distinct apoptotic pathways. Oncogene 9: 1791-1798, 1994.
16. Haldar S, Basu A and Croce CM: Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. Cancer Res 58: 1609-1615, 1998.
17. Haldar S, Basu A and Croce CM: Bcl2 is the guardian of microtubule integrity. Cancer Res 57i 229-233, 1997.
18. Haldar S, Chintapalli J and Croce CM: Taxol induces Bcl2 phosphorylation and death in prostate cancer cells. Cancer Res 56: 1253-1255, 1996.
19. Haldar S, Jena N and Croce CM: Inactivation of Bcl2 by phosphorylation. Proc Natl Acad Sci USA 92: 4507-4511, 1995.
20. Blagosklonny MV, Giannakakou P, El-Deiry WS, Kingston DGI, Higgs PI, Neckers L and Fozo T: Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res 57: 130-135, 1997.
21. Blagosklonny MV, Schulte T, Nguyen P, Trepel J and Neckers LM: Taxol-induced apoptosis and phosphorylation of bcl-2 protein involves c-Raf signal transduction pathway. Cancer Res 56: 1851-1854, 1996.
22. Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS and Longo DL: Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol 18: 3509-3517, 1998.
23. Hickman JA: Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11: 121-139, 1992.
24. Martin SJ and Cotter TG: Disruption of microtubules induces an endogenous suicide killing in human leukemia HL-60 cells. Cell Tissue Kinet 23: 545-559, 1990.
25. Jordan MA and Wilson L: Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 10: 123-130, 1998.
26. Ho SN, Hunt HD, Horton RM, Pullen JK and Pease LR: Site directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77: 51-59, 1989.
27. Tsujimoto Y and Croce CM: Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in follicular lymphoma. Proc Natl Acad Sci USA 83: 5214-5218, 1986.
28. Graham FL and van der Eb AJ: A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456-457, 1973.
29. Rowinsky EK, Onetto N, Canetta RM and Arbuck SG: Taxol, the first of the taxanes, an important new class of antitumor agents. Semin Oncol 19: 648-662, 1992.
30. Cohen PTW and Cohen P: Discovery of a protein phosphatase activity encoded in the genome of bacteriophage lambda. Probable identity with open reading frame 221. Biochem J 260: 931-934, 1989.
31. Zhou S, Clemens JC, Hakes DJ, Barford D and Dixon JE: Expression, purification, crystallization, and biochemical characterization of a recombinant protein phosphatase. J Biol Chem 268: 17754-17771, 1993.
32. Gordon JA: Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol 201: 477-482, 1991.
33. Ibrado AM, Liu L and Bhalla K: Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells. Cancer Res 57: 1109-1115, 1997.
34. Ito T, Deng X, Carr B and May WS: Bcl2 phosphorylation required for anti-apoptosis function. J Biol Chem 272: 11671-11673, 1997.
35. Lahti JM, Xiang J, Heath LS, Campana D and Kidd VJ: PITSLRE protein kinase activity is associated with apoptosis. Mol Cell Biol 15: 1-11, 1995.
36. Zanke BW, Lee C, Arab S and Tannock IF: Death of tumor cells after intracellular acidification is dependent on stress-activated protein kinases (SAPK/JNK) pathway activation and cannot be inhibited by Bcl-2 expression or interleukin 1β-converting enzyme inhibition. Cancer Res 58: 2801-2808, 1998.
37. Schmid-Allina A, Menou L, Manie S, Schmid-Antomarchi H, Millet M-A, Giuriato S, Ferruai B and Rossi B: Microtubule integrity regulates Src-like and extracellular signal-regulated kinase activities in human pro-monocytic cells. Importance for interleukin-1 production. J Biol Chem 273: 3394-3406, 1998.